Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Colonic Neoplasms × Trastuzumab × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 21 Stomach Neoplasms 6 Neoplasms 5 Esophageal Neoplasms 5 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Adenocarcinoma Of Esophagus 4 Triple Negative Breast Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 HER2-positive Breast Cancer 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Solid Tumors 1 Resectable HER2-positive Breast Cancer 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Meningeal Neoplasms 1 Malignant Solid Neoplasm 1 Hemangiosarcoma 1 HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients 1 HER2-positive Gastric Cancer 1 HER2-positive Early Breast Cancer 1 Gastroesophageal Adenocarcinoma 1 Gallbladder Neoplasms 1 Endometrial Neoplasms 1

Interventions

Oxaliplatin 10 Cetuximab 9 Bevacizumab 8 Leucovorin 6 Fluorouracil 6 pembrolizumab 5 Irinotecan 4 Pemetrexed 3 Gemcitabine 3 Cisplatin 3 Carboplatin 3 Capecitabine 3 adagrasib 2 Specimen Handling 2 Paclitaxel 2 Folfox protocol 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 sintilimab 1 ropidoxuridine 1 relatlimab 1 palbociclib 1 fludarabine 1 encorafenib 1 durvalumab 1 dostarlimab 1 dehydroftorafur 1 ceralasertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡